NTRR: Cannabis Industry Seeks Out New Solutions to Pesticide Problem
Dec 01, 2015
OTC Disclosure News Service
–
As Neutra Corp. (OTCQB: NTRR) continues working to deliver safer, better
solutions for cultivators across North America, cannabis businesses and
state agencies are still grappling with the use of potentially harmful
pesticides in the nascent industry. A recent independent study found
dangerous levels of pesticides in cannabis products in Denver.
A CNN report published on Wednesday discovered that at least one
over-the-counter cannabis concentrate tested positive for a neurotoxin
named imidacloprid. According to the Colorado Department of Agriculture,
it’s a chemical that cannot be used on cannabis crops. Due to CNN’s
sample finding, 2,362 cannabis products were voluntarily recalled
earlier in the month.
The city of Denver announced its ninth cannabis recall in 10 weeks over
pesticide concerns on November 18. The city now requires social-media
announcements for each recall. With the help of its joint venture
partners, NTRR is marketing cutting-edge technologies designed to help
reduce and eliminate the use of harsh chemicals in cannabis cultivation.
“Recalls are bad for the entire industry,” said NTRR CEO Chris Brown.
“Most growers are going out of their way to stay compliant with shifting
regulations, but there remains a clear need for superior products and
services that can help them produce strong, healthy crops without
relying upon harsh chemicals.”
Alongside joint venture partner Surface to Air Solutions (S2O2), NTRR
offers cannabis growers and other businesses a suite of horticultural
products—including a plant stimulant, an air-scrubber and a
self-cleaning hard surface treatment—that helps keep plants and surfaces
free from mold, powdery mildew, botrytis, and mites. These products
allow healthy plants to thrive without the use of pesticides and
fungicides. Its products are currently in use at growing facilities in
Colorado, Canada and Hawaii.
About Neutra Corp.
Neutra Corp. is a healthy lifestyle company that specializes in the
development and marketing of natural wellness solutions, including
cannabis-related products. By providing a variety of new technologies
designed to ensure safer, more reliable access to cannabis in approved
markets, Neutra Corp. plans to compete alongside GW Pharmaceuticals
(OTCBB: GWPRF), INSYS Therapeutics, Inc. (NASDAQ: INSY) and ENDEXX Corp.
(OTCBB: EDXC), delivering technological advancements in the cultivation
and processing of cannabis in approved markets. For investing
information and performance data, please visit www.neutracorp.com.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform
Act of 1995: This news release contains forward-looking information
within the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended, including statements that include the words “believes,”
“expects,” “anticipate” or similar expressions. Such forward-looking
statements involve known and unknown risks, uncertainties and other
factors that may cause the actual results, performance or achievements
of the Company to differ materially from those expressed or implied by
such forward-looking statements. In addition, description of anyone’s
past success, either financial or strategic, is no guarantee of success.
This news release speaks as of the date first set forth above and the
Company assumes no responsibility to update the information included
herein for events occurring after the date hereof.
View source version on businesswire.com: http://www.businesswire.com/news/home/20151201005663/en/
Copyright © 2015 Businesswire. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
